Self-reported side effects of semaglutide and tirzepatide in online communities - Nature Health
Researchers mined 410,198 Reddit posts (May 2019–June 2025) that mentioned semaglutide or tirzepatide and found 67,008 self-reported users. Of those, 43.5% described at least one side effect—mostly nausea, fatigue, vomiting, constipation and diarrhoea—while also flagging menstrual irregularities and temperature swings not well documented in trials or labels.
- Study mined 410,198 Reddit posts (2019–2025) and found 67,008 self-reported semaglutide/tirzepatide users, of whom 43.5% described at least one side effect.
- GI side effects (nausea 36.9%, fatigue 16.7%, vomiting 16.3%, constipation 15.3%, diarrhea 12.6%) roughly matched clinical trial data, but at much larger real-world scale.
- Users also reported menstrual irregularities and temperature-regulation issues (chills, hot flushes) that aren't documented in official drug labels or trials.
- Researchers shared their code on GitHub, showing social media mining as a viable tool for filling pharmacovigilance gaps.
Over six years, researchers pulled 410,198 Reddit posts that mentioned semaglutide or tirzepatide, focusing on self-reports from May 2019 to June 2025. Of 67,008 users who said they’d taken one of these GLP-1 receptor agonists, 43.5% described at least one side effect. Gastrointestinal complaints dominated: 36.9% reported nausea, 16.7% fatigue, 16.3% vomiting, 15.3% constipation and 12.6% diarrhea. Those numbers line up with clinical trials, but the sheer volume of real-world reports gave a clearer picture of how often these symptoms actually surface outside controlled settings.
Beyond the expected stomach issues, the analysis flagged less recognized effects. Users talked about menstrual irregularities, chills, hot flushes and other temperature-related problems. None of these made it into standard drug labels or major trial reports for semaglutide or tirzepatide. By scouring social media at scale and sharing their code on GitHub, the authors show how Reddit can fill gaps in pharmacovigilance. It’s a reminder that when thousands of people swap stories online, patterns emerge that might otherwise slip through the cracks.